Europe Digital Pathology Market

The digital pathology market in Europe is expected to grow from US$ 243.97 million in 2022 to US$ 474.42 million by 2028. It is estimated to grow at a CAGR of 11.7% from 2022 to 2028.

Growing Preference for Telepathology in Remote Areas Propels Growth of Digital Pathology Market in Europe

The dearth of pathology experts and the shortage of infrastructure required to run a pathology lab without any interruption are among the major issues faced in remote areas. With a digitized workflow, a pathologist can receive the slides of a patient in minutes instead of weeks; frozen section samples can be read and controlled remotely in real time, cutting travel time for the pathologist. People living in remote regions need to travel to urban areas for disease diagnosis, treatment, and follow-up, which is a primary concern that develops reluctance among them. Digital pathology helps bridge the gap between patients and diagnosing centers, as it provides the people staying in remote areas with effective access to healthcare organizations; it also helps save time and money for patients. The setup required for digital pathology can be easily adopted in rural labs and hospitals. Further, telepathology, which is described as a remote telecommunications consultation, primarily, for the diagnosis or treatment, helps close bridge the gap between two or more geographically distant healthcare providers by eliminating geographic and functional barriers. Several hospitals, primary care providers, private clinics, and other medical institutions offer telepathology services, which benefit them through cost reduction and patient satisfaction. Thus, the growing acceptance of telepathology is fuelling the digital pathology market growth.

Market Overview

The digital pathology market in Europe, based on country, is segmented into France, Germany, Italy, Spain, Poland, the UK, and the rest of Europe. The regional market growth is attributed to the increasing support for digital pathology projects, education, and training programs in France; rising prevalence of cancer; growing adoption of digital pathology solutions in the UK; and the surging number of conferences in Germany. Digital pathology process scans glass slides and produces virtual images. The virtual image is paired with associated clinical information to give pathologists an integrated picture of cancer patients. Pathologists can then perform additional diagnostics, including image analysis tests that cannot be done using traditional glass slides. These enhanced images can be viewed, annotated, and interpreted on a computer and used for cancer diagnosis and treatment. Furthermore, according to a study by Association of Clinical Pathologists, digital pathology adoption is high in the UK, and its usage is likely to increase in the coming years. In addition, pathologists in the UK seek guidance, training, and education on digital pathology solutions. Owing to the rising prevalence of cancer in the UK, the digital pathology market in the country is likely to grow during the forecast period

 Europe Digital Pathology Market Revenue and Forecast to 2028 (US$ Million)

Europe Digital Pathology Strategic Insights

Strategic insights for the Europe Digital Pathology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Digital Pathology Report Scope

Europe Digital Pathology Regional Insights

The geographic scope of the Europe Digital Pathology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Digital Pathology Market Segmentation

The Europe Digital Pathology Market is segmented into product , type, application and end user.

• Based on product, the market is segmented into scanners, software, storage and communication systems. The scanners segment registered the largest market share in 2022.
• Based on type, the market is segmented into human pathology, and veterinary pathology. The human pathology segment held the larger market share in 2022.
• Based on application, the market is segmented into drug discovery, disease diagnostics, teleconsultation, and training & education. The drug discovery segment held the larger market share in 2022.
• Based on end user, the market is segmented into pharma and biotech companies, hospital, and academic. The pharma and biotech companies segment held the largest market share in 2022.
• Based on country, the market is segmented into Germany ,France , the UK ,Italy ,Spain and the rest of Europe. The rest of Europe dominated the market share in 2022.

KoninklijkePhilipsN.V.;NikonCorporation;PerkinElmer,Inc.;IndicaLabs;3DHISTECHLtd.;Hamamatsu Photonics K.K.;F. Hoffmann-La RocheLtd;Visiopharm A/S;Glencoe Software, Inc.and; Danaher Corporation. are the leading companies operating in the digital pathology  in the region.